Update shared on 11 Dec 2025
Fair value Increased 0.98%Analysts have nudged their price target for Alimak Group slightly higher, from SEK 169.33 to SEK 171.00. They cited expectations of modestly improved profit margins offsetting somewhat slower projected revenue growth.
Valuation Changes
- The fair value estimate has risen slightly from SEK 169.33 to SEK 171.00, implying a modestly higher intrinsic valuation.
- The discount rate has inched up from 6.86 percent to approximately 6.86 percent, reflecting a marginally higher required return.
- Revenue growth has fallen moderately from about 3.37 percent to around 2.82 percent, signaling more cautious top line expectations.
- The net profit margin has risen slightly from roughly 12.97 percent to about 13.49 percent, indicating improved expected profitability.
- The future P/E has edged down from about 21.65 times to roughly 21.35 times, suggesting a marginally lower earnings multiple applied to future profits.
Have other thoughts on Alimak Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.